The cardiovascular intelligence infrastructure for the next generation of AI and healthcare.
D3H is building the AI-ready cardiovascular intelligence infrastructure powering pharmaceutical research, medical AI, and cardiovascular innovation.
The biggest bottleneck in cardiovascular AI isn't the algorithm. It's the data infrastructure.
Fragmented, limited, and slow data is holding back innovation, patient impact, and the next generation of therapies.
Fragmented Data
Siloed systems. Inconsistent formats.
Time Consuming
Months to collect and prepare data.
Poor Quality & Missing Data
Incomplete, noisy, and unstructured.
Regulatory Uncertainty
Hard to generate reliable evidence packages.
Weak data foundations lead to weak AI, failed trials, and missed opportunities.
From clinical data to cardiovascular intelligence.
The D3H Intelligence Refinery™ turns complex, fragmented data into AI-ready insights and commercial-grade evidence.
Raw Clinical Reality
- ECGs
- Echocardiography
- Imaging
- Clinical Notes
- Labs & Biomarkers
- Wearables & Devices
- Outcomes
- Multiple Sources
AI-Ready Intelligence
- Signal Access
- Patient Profiles
- Longitudinal Patients
- Evidence Cohorts
- Curated Studies
- Enterprise APIs
- Digital Biomarkers
- Validation Datasets
Built for cardiovascular AI. Designed for real-world impact.
Continuous Data Growth
Our dataset grows every month with new patients and longitudinal follow-ups.
Longitudinal Patients
Track disease evolution, treatment response, and outcomes over time.
Multimodal by Design
ECG, imaging, labs, treatments, devices, and outcomes—all linked.
AI-Ready Infrastructure
High-quality signals, clinical labels, feature library, and APIs ready to use.
Commercial Licensing
Clear, scalable, and compliant licensing for enterprise and research use.
Real-World Evidence
Generate clinical evidence that supports trials, submissions, and decision-making.
Feature Library & Labels
500+ engineered features and curated clinical labels.
QC Pipeline
100+ automated quality checks ensure reliability at every step.
From signals to evidence. Choose what you need.
Flexible data products and services that scale with your project—from raw signals to fully curated evidence.
Signal Access
Raw & processed ECG, imaging, and physiological signals.
Patient Profile
Demographics, clinical history, risk factors, labs, treatments.
Longitudinal Patient
Repeated measurements, timelines, outcomes, and treatment trajectories.
Evidence Cohort
Curated cohorts for specific indications or study criteria.
Curated Study
Custom datasets, annotations, analysis support, and documentation.
Enterprise API
Programmatic access, secure integration, and scalable delivery.
Save time. Reduce risk. Accelerate breakthroughs.
D3H eliminates data bottlenecks and delivers the longitudinal cardiovascular evidence you need—faster, cleaner, and ready to use.
Save Months of Work
Skip data collection, cleaning, and structuring. Start analysis in days.
From months to daysReduce Project Risk
High-quality, standardized, and clinically validated data you can trust.
Lower risk of failureAccelerate AI Development
AI-ready features, labels, and longitudinal context built-in.
Deploy in your pipelineImprove Study Efficiency
Rich data and outcomes reduce sample size and study duration.
Faster to insightLower Total Cost
Avoid redundant data efforts and expensive collection.
Lower overall costBetter data. Better decisions. Better outcomes.
|That's the value of cardiovascular intelligence infrastructure.
Purpose-built for the entire cardiovascular ecosystem.
Different challenges. One infrastructure. D3H delivers the right data, in the right format, for the right decision.
Pharma & Biotech
Pain Points
- • Need external validation
- • Limited access to digital biomarkers
- • Cardiotoxicity monitoring is expensive
Our Solution
- • Longitudinal cohorts
- • Clinical evidence
- • Custom datasets & biomarkers
You Receive
- • Real-world evidence
- • Digital biomarkers
- • Custom cohorts
- • Regulatory-grade data
Medical AI Companies
Pain Points
- • Lack of high-quality labels
- • Poor longitudinal context
- • Hard to access diverse, real-world data
Our Solution
- • AI-ready data & labels
- • Longitudinal patient journeys
- • Rich feature library
You Receive
- • Labeled datasets
- • AI-ready features
- • QC reports
- • API access
MedTech & Device Makers
Pain Points
- • Need real-world validation
- • Small internal datasets
- • Hard to prove generalizability
Our Solution
- • Multimodal data
- • Longitudinal outcomes
- • Diverse patient populations
You Receive
- • Validation cohorts
- • Performance benchmarks
- • Real-world evidence
- • Subgroup analyses
Hospitals & Health Systems
Pain Points
- • Limited data infrastructure
- • No time for data curation
- • Need benchmarking & outcomes insight
Our Solution
- • Easy access to curated datasets
- • Benchmarking datasets
- • Outcome & quality metrics
You Receive
- • Benchmark reports
- • Quality metrics
- • Outcome analytics
- • Collaborative datasets
Researchers & Academics
Pain Points
- • Hard to find rich datasets
- • No longitudinal follow-up
- • Low reproducibility
Our Solution
- • High-quality, well-documented datasets
- • Longitudinal & multimodal data
You Receive
- • Research datasets
- • Cohorts for studies
- • Reproducible data
- • Data dictionaries
One infrastructure. Many possibilities. Real impact across the entire cardiovascular value chain.
A compounding infrastructure built for lasting advantage.
D3H is not just a dataset. It's a continuously growing cardiovascular intelligence infrastructure that gets smarter, deeper, and more valuable over time.
Continuous Growth
Data, features, and evidence grow every day—powered by real-world clinical activity.
Built for Longitudinal Depth
Repeated measurements and outcomes enable deeper insights and stronger models.
Commercial-Ready
Licensed, compliant, and easy to integrate into your existing workflows.
Evidence That Compounds
More data. More outcomes. Stronger signals. Greater confidence.
Infrastructure. Not Just Data
From raw signals to AI-ready insights—purpose-built for the future.
Built to Last
Quality, governance, and security designed for scale and sustainability.
Key Members
Dr. Ali Arababadi
CEO & Co-Founder
10+ years of leadership in engineering and business development
Dr. Meysam Arababadi
CPO & Co-Founder
Proven track record as CEO of Pinvest, a tech startup in wealth management
Kianoosh Aryanfar
CIO & Co-Founder
Proven track record as CTO of Pinvest, a tech startup in wealth management
Build better. Decide faster. Save lives.
Partner with D3H and unlock the power of cardiovascular intelligence infrastructure.